• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.

作者信息

Nishio S, Horii A, Morikawa Y, Kawakita J, Nishijima T, Kishimoto T, Maekawa M

出版信息

Invest Urol. 1979 Mar;16(5):336-41.

PMID:429127
Abstract

The nonspecific cellular immune response, as measured by phytohemagglutinin (PHA)-induced blastoid transformation of peripheral lymphocytes in autologous serum, was evaluated in 119 patients with bladder carcinoma and in 21 control subjects. Blastoid transformation was determined by quantifying 3H-thymidine incorporation (counts per minute). The rate of blastogenesis of lymphocytes was shown as the stimulation index which was calculated by dividing the number of counts per minute with PHA by that without PHA. The stimulation index of the control subjects was 29.9 +/- 6.6 (+/- SD); that of the experimental group was 13.3 +/- 7 (significantly lower reactivity). There was a converse correlation between the stimulation index and the grade and stage of tumor. In some cases the change in cellular immunity was compared before and after surgery.

摘要

相似文献

1
Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Invest Urol. 1979 Mar;16(5):336-41.
2
Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.膀胱癌患者非特异性细胞免疫反应的研究。II. 膀胱癌患者血清的免疫抑制作用。
Invest Urol. 1979 Mar;16(5):342-5.
3
In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
Natl Cancer Inst Monogr. 1978 Dec(49):119-22.
4
[Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Hinyokika Kiyo. 1984 Apr;30(4):449-57.
5
Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.循环细胞毒性淋巴细胞对膀胱癌患者自体肿瘤的预后意义。
J Urol. 1996 Mar;155(3):888-92; discussion 892-4.
6
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
Natl Cancer Inst Monogr. 1978 Dec(49):111-4.
7
Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.膀胱癌患者的淋巴细胞亚群、淋巴细胞对有丝分裂原的反应性、自然杀伤细胞活性以及中性粒细胞和单核细胞的吞噬功能。
Anticancer Res. 2003 Nov-Dec;23(6D):5185-9.
8
Prognostic significance of soluble Fas in the serum of patients with bladder cancer.可溶性Fas在膀胱癌患者血清中的预后意义
J Urol. 1998 Aug;160(2):571-6.
9
Studies on nonspecific cellular immune response in patients with urinary bladder carcinoma.
Osaka City Med J. 1978;24(1):51-71.
10
[RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].[膀胱癌患者的红细胞和T淋巴细胞亚群:免疫学研究]
Zhonghua Wai Ke Za Zhi. 1999 Feb;37(2):113-6.

引用本文的文献

1
Serial immune function testing to predict clinical disease relapse in patients with solid tumors.通过系列免疫功能检测预测实体瘤患者的临床疾病复发
Cancer Immunol Immunother. 1983;15(3):165-71. doi: 10.1007/BF00199159.
2
Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.膀胱癌患者外周血T细胞亚群的特征分析
Urol Res. 1991;19(4):219-22. doi: 10.1007/BF00305298.